Anti-Inflammatory and Anti-Coagulant Effects of Salmon Polar Lipids

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

November 15, 2019

Study Completion Date

December 15, 2019

Conditions
Platelet Thrombus
Interventions
DIETARY_SUPPLEMENT

Food Grade Extract of Salmon Polar Lipids (FGE-Salmon-PLs)

Each participant will be administered per day a capsule of the FGE-Salmon-PLs food supplement (containing 0.125 g of FGE-Salmon-PLs) for a period of 28 days in a double blind randomized, crossover and placebo-controlled design.

OTHER

Placebo

Each participant will be administered per day a placebo capsule (containing 0.125 g of glycerin) for a period of 28 days in a double blind randomized, crossover design.

Trial Locations (1)

V94 T9PX

University of Limerick, Limerick

All Listed Sponsors
lead

University of Limerick

OTHER

NCT03866265 - Anti-Inflammatory and Anti-Coagulant Effects of Salmon Polar Lipids | Biotech Hunter | Biotech Hunter